comparemela.com

Latest Breaking News On - Cannabidiol oral solution - Page 1 : comparemela.com

India-based Pharmaceuticals Biphore and Zenara Get CDSCO Approval for Neuro Disorder Drug

Indian pharmaceutical companies Biophore and its subsidiary Zenara Pharma in Hyderabad get approval from the CDSCO for manufacturing and marketing of neuro disorder drug.

Andhra pradeshZenara pharmaCentral drugs standard control organizationBiophore india pharmaceuticalsHyderabad based biophore india pharmaceuticalsCannabidiol oral solutionCannabidiol legalIndian pharmaceuticalEuro disorder drugLennox gastaut syndromeDravet syndromeReatment of seizuresCannabidiol oral solution

Biphore, Zenara get CDSCO approval for neuro disorder drug

Hyderabad-based Biophore India Pharmaceuticals has announced that it has received approval from he Central Drugs Standard Control.

Andhra pradeshJagadeesh babu rangisettyZenara pharmaCentral drugs standard control organisationBiophore india pharmaceuticalsCannabidiol oral solution

Biphore, Zenara get CDSCO approval for neuro disorder drug

Hyderabad-based Biophore India Pharmaceuticals has announced that it has received approval from he Central Drugs Standard Control Organisation (CDSCO) for manufacturing and marketing of Cannabidiol active ingredient in India.Its subsidiary, .

Andhra pradeshZenara pharmaJagadeesh babu rangisettyBiophore india pharmaceuticalsCentral drugs standard control organisationHyderabad based biophore india pharmaceuticalsCannabidiol oral solution

Hyderabad: Biphore, Zenara get CDSCO approval for neuro disorder drug

Hyderabad: Hyderabad-based Biophore India Pharmaceuticals has announced that it has received approval from he Central Drugs Standard Control Organisation

Andhra pradeshJagadeesh babu rangisettyZenara pharmaCentral drugs standard control organisationBiophore india pharmaceuticalsHyderabad based biophore india pharmaceuticalsCannabidiol oral solution

Epilepsy Monitoring Devices Market Size to Surpass USD 1,510 51 Million by 2030, Share, Growth, Demand, Global Trends, Segmentation and Competitive Outlook

Epilepsy Monitoring Devices Market is the title of a new report from Data Bridge Market Research. Key growth strategies, drivers, opportunities, key segments,

United statesHong kongUnited kingdomNew zealandSouth koreaRepublic ofSouth africaEastern capeSaudi arabiaBowers wilkinsCompany landscapeCompany profiles of key playersSurgical centersDownload the complete research studyMarket researchBrowsea detailed summary of the research

vimarsana © 2020. All Rights Reserved.